What we do

Business Areas

Bioprinting

In vitro human tissue models that reduce testing costs and animal testing in the cosmetics, chemical, pharmaceutical and household industries.

Bioprinting

In vitro human tissue models that reduce testing costs and animal testing in the cosmetics, chemical, pharmaceutical and household industries.

Learn more

Biosciences

Providing user-friendly instruments to bring efficiency and speed to multiple application areas.

Biosciences

Providing user-friendly instruments to bring efficiency and speed to multiple application areas.

Learn more

Bioautomation

Accelerating development and manufacturing of diagnostic and bioanalysis test platforms.

Bioautomation

Accelerating development and manufacturing of diagnostic and bioanalysis test platforms.

Learn more
Bioprinting
In vitro human tissue models that reduce testing costs and animal testing in the cosmetics, chemical, pharmaceutical and household industries.

Learn more
Biosciences
Providing user-friendly instruments to bring efficiency and speed to multiple application areas.

Learn more
Bioautomation
Accelerating development and manufacturing of diagnostic and bioanalysis test platforms.

Learn more
NXCIS test
NXCIS test
NXCIS test
NXCIS test
NXCIS test
NXCIS test
NXCIS test
NXCIS test
NXCIS test
NXCIS test
BICO consists of several subsidiaries organized into three business areas. Together, we aim to reduce the world’s organ shortage and speed up drug development by providing accessible life science solutions that combine biology and technology.
Learn more about our companies

BICO consists of several subsidiaries organized into three business areas. Together, we aim to reduce the world’s organ shortage and speed up drug development by providing accessible life science solutions that combine biology and technology.

 

Learn more about our companies

Products

0 +
Installations
0 +
Labs
0 +
Countries

We’re equipping hundreds of labs and thousands of scientists worldwide with cutting-edge technologies that fuel groundbreaking scientific breakthroughs.

With a commitment to quality and innovation, our technologies, products and services have contributed to revolutionary advancements in the life science industry.
With a commitment to quality and innovation, our technologies, products and services have contributed to revolutionary advancements in the life science industry.

Explore customer spotlights

Explore product portfolio

Converging for multiple speed

Synergies enabling automated workflows for faster drug discovery

Converging for multiple speed

Synergies enabling automated workflows for faster drug discovery

Learn more

Sustainability

Learn more

Sustainability

BICO’s sustainability agenda connects bioconvergence with three different perspectives that define our operations with UN Sustainability Development Goals.
As of December 2021, BICO is an official signatory of the UN Global Compact Sustainability Development Goals and the Ten Principles of the United Nations Global Compact.

Learn more about our sustainability agenda

100 +

Animals saved

100 +

Animals saved

BICO’s efforts pushing for animal-free testing, already saving more than 100,000 animal lives, is in step with recent legislation.

In December 2022, The U.S. Congress passed the FDA Modernization Act 2.0. This means that animal testing will no longer be required for market approval.

A historic milestone in the acceptance of alternatives to animal models in drug discovery. Alternatives that capture human physiology better, that are more ethical, sustainable and most importantly can accelerate the discovery of life changing therapies.

Learn more